An age-structured epidemic model of rotavirus with vaccination

Journal of Mathematical Biology

Volumn 53, Issue 4, 2006, Pages 719-746

  Shim, E ^a   Feng, Z ^b   Martcheva, M ^c   Castillo Chavez, C ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Age structure; Rotavirus; Vacccination

Indexed keywords

ROTAVIRUS VACCINE;

AGE; ALGORITHM; ARTICLE; BIOLOGICAL MODEL; DISEASE TRANSMISSION; ENDEMIC DISEASE; EPIDEMIC; HUMAN; IMMUNOLOGY; PASSIVE IMMUNIZATION; ROTAVIRUS INFECTION; VIRUS INFECTION;

AGE FACTORS; ALGORITHMS; DISEASE OUTBREAKS; DISEASE TRANSMISSION, HORIZONTAL; DISEASE TRANSMISSION, INFECTIOUS; ENDEMIC DISEASES; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; MODELS, BIOLOGICAL; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

ROTAVIRUS;

EID: 33748312039     PISSN: 03036812     EISSN: 14321416     Source Type: Journal    
DOI: 10.1007/s00285-006-0023-0     Document Type: Article

References (34)

1. Anguelov, R., Lubuma, J.M.-S.: Contributions to the mathematics of the nonstandard finite difference method and applications. Numer. Methods Part. Diff. Eq. 17(5), 518-543 (2001)
2. Bernstein, D.I., Sander, D.S., Smith, V.E., Schiff, G.M, Ward, RL.: Protection from rotavirus reinfection: 2-year prospective study. J. Infect. Dis. 164(2), 277-283 (1991)
3. Bishop, R.F., Davidson, G.P., Holmes, I.H., Ruck, B.J.: Virus particles in epithelial cells of duodenal mucosa from children with viral gastroenteritis. Lancet 1, 1281-1283 (1973)
4. Bishop, R.F., Barnes, G.L., Cipriani, E., Lund, J.S.: Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N. Engl. J. Med. 309(2), 72-76 (1983)
5. Busenberg, S., Castillo-Chavez, C.: A general solution of the problem of mixing subpopulations, and its application to risk- and age-structure epidemic models for the spread of AIDS. IMA. J. Math. Appl. Med. Biol. 8(1), 1-29 (1991)
6. Castillo-Chavez, C., Feng, Z.: Global stability of an age-structure model for TB and its applications to optimal vaccination strategies. Math. Biosc. 151(2), 135-154 (1998)
7. Clark, H.F., Lawley, D., Shrager, D., Jean-Guillaume, D., Offit, P.A., Whang, S.Y., Eiden, J.J., Bennett, P.S., Kaplan, K.M., Shaw, A.R.: Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4. Pediatr. Infect. Dis. J. 23(3), 206-211 (2004)
8. Cunliffe, N.A., Bresee, J.S., Hart, C.A.: Rotavirus vaccines: development, current issues and future prospects. J. Infect. 45(1), 1-9 (2002)
9. Dennehy, PH.: Rotavirus vaccines: an update. Curr. Opin. Pediatr. 17(1), 88-92 (2005)
10. Dietz, K., Schenzle, D.: Proportionate mixing models for age-dependent infection transmission. J. Math Biol. 22(1), 117-120 (1985)
11. Gripenberg, G., Londen S.O., Staffans, O.: Volterra Integral and Functional Equations. Series: Encyclopedia of Mathematics and its Applications (No. 34). Cambridge (1990)
12. Hadeler, K.P., Müller, J.: Vaccination in age-structured populations II: optimal vaccination strategies. In: Isham, V., Medley, G., (ed.) Models for Infectious Human Diseases: Their Structure and Relation to Data, pp. 102-114. Cambridge University Press, Cambridge (1993)
13. Hadeler, K.P., Müller, J.: Optimal harvesting and optimal vaccination, (In submission)
14. Hardy, D.: Epidemiology of rotaviral infection in adults. Rev. Infect. Dis. 9, 461-469 (1987)
15. Hochwald, C., Kivela, L.: Rotavirus vaccine, live, oral, tetravalent (RotaShield). Pediatr. Nurs. 25(2), 203-204, 207 (1999)
16. Huang, W., Castillo-Chavez, C.: Age-structured core groups and their impact on HIV dynamics. In: Mathematical Approaches for Emerging and Reemerging Infectious Diseases: Models, Methods and Theory, IMA, vol. 126, pp. 261-273, Springer, Berlin Heidelberg New York
17. Iannelli, M., Milner, F., Pugliese, A.: Analytical and numerical results for the age structured SIS epidemic model with mixed inter-intra-cohort transmission. SIAM J. Math. Anal. Publ. Soc. Indust. Appl. Math. 23, 662-688 (1992)
18. Kapikian, A.Z., Kim, H.W., Wyatt, R.G., Cline, W.L., Arrobio, J.O., Brandt, C.D., Rodriguez, W.J., Sack, D.A., Chanock, R.M, Parrott, R.H.: Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N. Engl. J. Med. 294, 965-972 (1976)
19. Kapikian, A.Z., Wyatt, R.G., Levine, M.M. et al.: Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J. Infect. Dis. 147, 95-106 (1983)
20. Kribs-Zaleta, C.M., Martcheva, M.: Vaccination strategies and backward bifurcation in an age-since-infection structured model. Math. Biosci. 177-178, 317-332 (2002)
21. Mastretta, E., Longo, P., Laccisaglia, A., Balbo, L., Russo, R., Mazzaccara, A., Gianino, P.: Effect of lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J. Pediat. Gastroenterol. Nutr. 35(4), 527-531 (2002)
22. Mickens, R.E.: (ed.) Advances in the Applications of Nonstandard Finite Difference Schemes. World Scientific Publishing Company, Singapore (2005)
23. Nguyen T.V., Yuan L., P Azevedo M.S., Jeong K.I., Gonzalez A.M., Iosef C., Lovgren-Bengtsson K., Morein B., Lewis P., Saif, L.J.: Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine. Vaccine 24(13), 2302-2316 (2006)
24. Parashar, U.D., Bresee, J.S., Gentsch, J.R., Glass, R.I.: Rotavirus. Emerg. Infect. Dis. 4(4), 561-570 (1998)
25. Parashar, U.D., Holman, R.C., Clarke, M.J., Bresee, J.S., Glass, R.I.: Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J. Infect. Dis. 177(1), 7-13 (1998)
26. Pérez-Schael, I., Guntiñas, M.J., Pérez, M., Pagone, V., Rojas, A.M., González, R., Cunto, W., Hoshino, Y., Kapikian, A.Z.: Efficacy of the Rhesus RotavirusDBased Quadrivalent Vaccine in Infants and Young Children in Venezuela. N. Engl. J. Med. 337(17), 1181-1187 (1997)
27. Ramos, P D, Stefanelli, C C, Linhares, R E C et al.: The infectivity of pig rotavirus in stools. Braz. J. Vet. Res. Anim. Sci. 35(2), 00-00 (1998)
28. Rorres, C., Fair, W.: Optimal harvesting policy for an age-specific population. Math. Biosci. 24, 31-47 (1975)
29. Rotavirus Vaccine Program: A path affiliate. As found at http://www.rotavirusvaccine.org/vaccine-facts.htm
30. Shim, E., Banks, T.B., Castillo-Chavez, C.: Seasonality of rotavirus infection with its vaccination. In: Gumel A. (Chief Ed.), Castillo-Chavez, C., Clemence, D.P. and Mickens, R.E (eds.) Modeling The Dynamics of Human Diseases: Emerging Paradigms and Challenges. AMS Cotempor. Math. Ser. (to appear).
31. Velazquez, F.R., Matson, D.O., Guerrero, M.L., Shults, J., Calva, J.J., Morrow, A.L., Glass, R.I., Pickering, L.K., Ruiz-Palacios, G.M.: Serum antibody as a marker of protection against natural rotavirus infection and disease. J. Infect. Dis. 182(6), 1602-1609 (2000)
32. Vesikari, T. Clark, H.F., Offit, P.A., et al.: The effect of dose and composition of a pentavalent rotavirus vaccine (RotaTeq) upon safety, efficacy, and immunogenicity in healthy infants. In: Presented at the 22nd Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID), Tampere, Finland, 26-28, (2004)
33. Vesikari, T., Giaquinto, C., Huppertz, H.I.: Clinical trials of rotavirus vaccines in europe. Pediatr. Infect. Dis. J. 25(1), S42-7 (2006)
34. Ward, R.L., Bernstein D.I.: Protection against rotavirus disease after natural rotavirus infection. US Rotavirus Vaccine Efficacy Group. J. Infect. Dis. 169(4), 900-904 (1994)